Johnson & Johnson Introduces VARIPULSE Pulsed Field Ablation Platform in India

Digital Health News announces Johnson & Johnson’s launch of a new cardiac therapy in India. The technology uses pulsed field ablation to treat heart rhythm disorders. It is marketed under the VARIPULSE platform name. Introducing the system expands J&J’s medical device portfolio locally. The rollout targets hospitals and electrophysiology centers across India. Pulsed field ablation promises faster procedures with reduced tissue damage. Regulators have approved the platform for clinical use in the country. Observers will watch adoption rates and patient outcomes in the coming months.